Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34954155)

  • 1. TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer.
    Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
    Int J Biochem Cell Biol; 2022 Feb; 143():106140. PubMed ID: 34954155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer" [Int. J. Biochem. Cell Biol. 143 (2022) 106140].
    Wang J; Yang F; Zhuang J; Huo Q; Li J; Xie N
    Int J Biochem Cell Biol; 2022 Mar; 144():106157. PubMed ID: 35067396
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
    Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
    Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
    Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
    World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.
    Sun M; Zhou T; Jonasch E; Jope RS
    Biochim Biophys Acta; 2013 Jun; 1833(6):1489-97. PubMed ID: 23470959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.
    Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
    Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
    Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
    Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
    Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
    Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
    Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
    J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Zheng YZ; Li JY; Ning LW; Xie N
    Breast Cancer (Dove Med Press); 2022; 14():475-487. PubMed ID: 36578908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.
    Chen WJ; Wang WT; Tsai TY; Li HK; Lee YW
    Sci Rep; 2017 Aug; 7(1):9411. PubMed ID: 28842590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
    Vellky JE; McSweeney ST; Ricke EA; Ricke WA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
    Li X; Jiang J; Wu Q; You T; Yang F
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38714850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
    Oliver PG; LoBuglio AF; Zhou T; Forero A; Kim H; Zinn KR; Zhai G; Li Y; Lee CH; Buchsbaum DJ
    Breast Cancer Res Treat; 2012 Jun; 133(2):417-26. PubMed ID: 21901385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.